Southwestern Behavioral Care Latrobe Office

Substance use treatment Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Outpatient

Outpatient mental health facility

Chlorpromazine Droperidol Fluphenazine Haloperidol Loxapine Perphenazine Pimozide Prochlorperazine Thiothixene Thioridazine Trifluoperazine Aripiprazole Asenapine Brexpiprazole Cariprazine Clozapine IIoperidone Lurasidone Olanzapine Olanzapine/Fluoxetine combination Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Non-nicotine smoking/tobacco cessation Antipsychotics used in treatment of SMI

Activity therapy Cognitive behavioral therapy Couples/family therapy Dialectical behavior therapy Group therapy Integrated Mental and Substance Use Disorder treatment Individual psychotherapy Telemedicine/telehealth therapy Abnormal involuntary movement scale

Private non-profit organization

County or local government funds Community Mental Health Block Grants Medicaid Other State funds Private health insurance State corrections or juvenile justice funds Cash or self-payment State-financed health insurance plan other than Medicaid State mental health agency (or equivalent) funds State welfare or child and family services funds

Seniors or older adults Clients with co-occurring mental and substance use disorders Clients who have experienced trauma Persons with post-traumatic stress disorder (PTSD) Children/adolescents with serious emotional disturbance (SED) Persons 18 and older with serious mental illness (SMI)

Screening for tobacco use

Smoking/vaping/tobacco cessation counseling

Smoking permitted in designated area

Children/Adolescents Young Adults Adults Seniors

Vaping permitted in designated area

Chronic disease/illness management Court-ordered outpatient treatment Family psychoeducation Illness management and recovery Suicide prevention services Education services